Physicians compare the merits of Botox Cosmetic, Dysport and Xeomin, as a new wave of toxins vies for approval.
“Botox is still the gold standard, best studied and most widely used. It is also the most costly, and the prices keep rising.” .
All three currently approved neurotoxin products are Type A botulinum toxins. Significant differences relate to dosing and reconstitution.
Although it has been used off-label for crow’s feet for years, the FDA approval of Botox Cosmetic for this indication is driving new patients to aesthetic practices.
“Diffusion can be dose related or related to the reconstitution volume.”
The main differentiating point for Xeomin is that it does not require refrigeration.
Many physicians and consumers are eagerly awaiting approval of topical botulinum toxins.